{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:12:59Z","timestamp":1791501179122,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1245\/s10434-023-13889-3","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T21:01:49Z","timestamp":1689454909000},"page":"6170-6175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)"],"prefix":"10.1245","volume":"30","author":[{"given":"Rachel L.","family":"O\u2019Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"El-Sharkawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoma D.","family":"Attygalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"MacNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios-Konstantinos","family":"Tasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"2","key":"13889_CR1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","volume":"100","author":"JA Keech Jr","year":"1997","unstructured":"Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100(2):554\u20135.","journal-title":"Plast Reconstr Surg."},{"issue":"20","key":"13889_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 Revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood."},{"key":"13889_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpra.2022.08.008","volume":"34","author":"K Sharma","year":"2022","unstructured":"Sharma K, Gilmour A, Jones G, O\u2019Donoghue JM, Clemens MW. A Systematic review of outcomes following breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). JPRAS Open. 2022;34:178\u201388.","journal-title":"JPRAS Open."},{"issue":"2","key":"13889_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","volume":"32","author":"RN Miranda","year":"2014","unstructured":"Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32(2):114\u201320.","journal-title":"J Clin Oncol."},{"issue":"2","key":"13889_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","volume":"34","author":"MW Clemens","year":"2016","unstructured":"Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34(2):160\u20138.","journal-title":"J Clin Oncol."},{"issue":"2","key":"13889_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejso.2020.07.043","volume":"47","author":"P Turton","year":"2021","unstructured":"Turton P, El-Sharkawi D, Lyburn I, Sharma B, Mahalingam P, Turner SD, et al. UK guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) on behalf of the medicines and healthcare products regulatory agency (MHRA) plastic, reconstructive and aesthetic surgery expert advisory group (PRASEAG). Eur J Surg Oncol. 2021;47(2):199\u2013210.","journal-title":"Eur J Surg Oncol."},{"key":"13889_CR7","doi-asserted-by":"crossref","unstructured":"Santanelli di Pompeo F, Sorotos M, Clemens MW, Firmani G, Safety EAoPSCoD, Development. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of Epidemiology and Prevalence Assessment in Europe. Aesthet Surg J. 2020;41(9):1014\u201325.","DOI":"10.1093\/asj\/sjaa285"},{"issue":"5","key":"13889_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bjps.2019.11.064","volume":"73","author":"PG Cordeiro","year":"2020","unstructured":"Cordeiro PG, Ghione P, Ni A, Hu Q, Ganesan N, Galasso N, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plastic Reconstruct Aesthet Surg. 2020;73(5):841\u20136.","journal-title":"J Plastic Reconstruct Aesthet Surg."},{"issue":"3","key":"13889_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","volume":"4","author":"M de Boer","year":"2018","unstructured":"de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, et al. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol. 2018;4(3):335\u201341.","journal-title":"JAMA Oncol."},{"key":"13889_CR10","doi-asserted-by":"crossref","unstructured":"Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2017;139(5):1042\u201350.","DOI":"10.1097\/PRS.0000000000003282"},{"key":"13889_CR11","doi-asserted-by":"crossref","unstructured":"Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Plast Reconstr Surg. 2019;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S\u201340S.","DOI":"10.1097\/PRS.0000000000005567"},{"key":"13889_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2021.104982","volume":"125","author":"WH De Jong","year":"2021","unstructured":"De Jong WH, Panagiotakos D, Proykova A, Samaras T, Clemens MW, De Jong D, et al. Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: Report of the scientific committee on health, emerging and environmental risks (SCHEER). Regul Toxicol Pharmacol: RTP. 2021;125:104982.","journal-title":"Regul Toxicol Pharmacol: RTP."},{"key":"13889_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpra.2021.11.006","volume":"32","author":"SS Lajevardi","year":"2022","unstructured":"Lajevardi SS, Rastogi P, Isacson D, Deva AK. What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)? JPRAS Open. 2022;32:34\u201342.","journal-title":"JPRAS Open."},{"issue":"4","key":"13889_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4274\/ejbh.galenos.2021.2021-5-6","volume":"17","author":"P Ionescu","year":"2021","unstructured":"Ionescu P, Vibert F, Am\u00e9 S, Mathelin C. New data on the epidemiology of breast implant-associated anaplastic large cell lymphoma. Eur J Breast Health. 2021;17(4):302\u20137.","journal-title":"Eur J Breast Health."},{"key":"13889_CR15","doi-asserted-by":"crossref","unstructured":"Oishi N, Miranda RN, Feldman AL. Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Supplement_1):S14-S20.","DOI":"10.1093\/asj\/sjy308"},{"key":"13889_CR16","first-page":"5647940","volume":"2019","author":"J Adlard","year":"2019","unstructured":"Adlard J, Burton C, Turton P. Increasing evidence for the association of breast implant-associated anaplastic large cell lymphoma and Li Fraumeni syndrome. Case Rep Genet. 2019;2019:5647940.","journal-title":"Case Rep. Genet."},{"key":"13889_CR17","doi-asserted-by":"crossref","unstructured":"Hallab NJ, Samelko L, Hammond D. The inflammatory effects of breast implant particulate shedding: comparison with orthopedic implants. Aesthet Surg J. 2019;39(Supplement_1):S36-S48.","DOI":"10.1093\/asj\/sjy335"},{"key":"13889_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biomaterials.2015.06.010","volume":"67","author":"JP Giot","year":"2015","unstructured":"Giot JP, Paek LS, Nizard N, El-Diwany M, Gaboury LA, Nelea M, et al. The double capsules in macro-textured breast implants. Biomaterials. 2015;67:65\u201372.","journal-title":"Biomaterials."},{"key":"13889_CR19","doi-asserted-by":"crossref","unstructured":"Turner SD. The cellular origins of breast implant\u2013associated anaplastic large cell lymphoma (BIA-ALCL): implications for immunogenesis. Aesthet Surg J. 2019;39(Supplement_1):S21-S7.","DOI":"10.1093\/asj\/sjy229"},{"key":"13889_CR20","doi-asserted-by":"crossref","unstructured":"Kadin ME. What cytokines can tell us about the pathogenesis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Supplement_1):S28\u201335.","DOI":"10.1093\/asj\/sjy250"},{"issue":"5","key":"13889_CR21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ejso.2020.10.029","volume":"47","author":"M Rond\u00f3n-Lagos","year":"2021","unstructured":"Rond\u00f3n-Lagos M, Rangel N, Camargo-Villalba G, Forero-Castro M. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Eur J Surg Oncol. 2021;47(5):942\u201351.","journal-title":"Eur J Surg Oncol."},{"key":"13889_CR22","doi-asserted-by":"crossref","unstructured":"Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Suppl_1):S3-S13.","DOI":"10.1093\/asj\/sjy331"},{"key":"13889_CR23","doi-asserted-by":"crossref","unstructured":"Santanelli di Pompeo F, Clemens MW, Atlan M, Botti G, Cordeiro PG, De Jong D, et al. 2022 Practice recommendation updates from the world consensus conference on BIA-ALCL. Aesthet Surg J. 2022;42(11):1262-78.","DOI":"10.1093\/asj\/sjac133"},{"issue":"2","key":"13889_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/annonc\/mdv575","volume":"27","author":"C Laurent","year":"2016","unstructured":"Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016;27(2):306\u201314.","journal-title":"Ann Oncol."},{"issue":"1","key":"13889_CR25","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1097\/SLA.0000000000004035","volume":"275","author":"SE Tevis","year":"2022","unstructured":"Tevis SE, Hunt KK, Miranda RN, Lange C, Pinnix CC, Iyer S, et al. Breast Implant-associated anaplastic large cell lymphoma: a prospective series of 52 patients. Ann Surg. 2022;275(1):e245\u20139.","journal-title":"Ann Surg."},{"issue":"9","key":"13889_CR26","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1245\/s10434-022-11838-0","volume":"29","author":"HA Lillemoe","year":"2022","unstructured":"Lillemoe HA, Miranda RN, Nastoupil LJ, Clemens MW, Hunt KK. Clinical manifestations and surgical management of breast implant-associated anaplastic large cell lymphoma: beyond the NCCN guidelines. Ann Surg Oncol. 2022;29(9):5722\u20139.","journal-title":"Ann Surg Oncol."},{"key":"13889_CR27","doi-asserted-by":"crossref","unstructured":"Lamaris GA, Butler CE, Deva AK, Miranda RN, Hunt KK, Connell T, et al. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-8S.","DOI":"10.1097\/PRS.0000000000005569"},{"key":"13889_CR28","doi-asserted-by":"crossref","unstructured":"Lee WS, Kim TG, Lee JH, Kim IK. Breast reconstruction after breast implant-associated anaplastic large cell lymphoma treatment: a case report and literature review. J Clin Med. 2023;12(5).","DOI":"10.3390\/jcm12051885"},{"key":"13889_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.breast.2022.11.009","volume":"66","author":"B Longo","year":"2022","unstructured":"Longo B, Di Napoli A, Curigliano G, Veronesi P, Pileri S, Martelli M, et al. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL. Breast (Edinburgh, Scotland). 2022;66:332\u201341.","journal-title":"Breast (Edinburgh, Scotland)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13889-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13889-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13889-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T14:03:08Z","timestamp":1694440988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13889-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["13889"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13889-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant conflicts of interest to declare. These are our disclosures of any associations, though we do not feel they are relevant to this research study. ROC: Speaker honoraria with Astra Zenica and Merck. MKT: Consultancy for BMJ Publishing Group; Speakers Bureau at Integra Life Sciences. D E-S: Honoraria from Abbvie, AstraZeneca, Beigene, Gilead, Janssen, Lily, Roche, Takeda; Conference\/Travel support: Abbvie, Novartis, Roche; Advisory boards: Abbvie, ASTEX, AstraZeneca, Beigene, Janssen, Kyowa Kiirin. AA, AW, AAK, FAM and BS: no associations to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}